Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
International Journal of Technology Assessment in Health Care
|
May 24, 2022
Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework - Corrigendum
Amanda Whittal, Claudio Jommi, Gérard De Pouvourville, et al.
International Journal of Technology Assessment in Health Care
|
March 11, 2022
Facilitating [corrected] More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework
Amanda Whittal, Claudio Jommi, Gérard De Pouvourville, et al.
BMC Health Services Research
|
January 23, 2024
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Maria Caterina Cavallo, Marianna Cavazza, Francesca Bonifazi, et al.
Bioactive Materials
|
July 17, 2023
Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access
Lorella Giovannelli, Elia Bari, Claudio Jommi, et al.
Health Policy (Amsterdam, Netherlands)
|
May 18, 2019
Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency
Federico Villa, Michaela Tutone, Gianluca Altamura, et al.
Applied Health Economics and Health Policy
|
August 9, 2018
Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates
Jaime Espin, Michael Schlander, Brian Godman, et al.
Health Economics Review
|
November 26, 2025
Horizon scanning and drug expenditure for rare diseases: three-year predictive model in Italy 2025-2027
Andrea Marcellusi, Daniela Cazzato, Giulio Guarnotta, et al.
Frontiers in Medicine
|
June 16, 2023
Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries
Miguel Á Canales Albendea, Pier Luigi Canonico, Guillaume Cartron, et al.
Pharmacoeconomics - Open
|
April 7, 2018
The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational Study
Claudio Jommi, Patrizio Armeni, Margherita Battista, et al.
Journal of Market Access & Health Policy
|
July 26, 2017
Unlocking the potential of established products: toward new incentives rewarding innovation in Europe
Gabrielle Nayroles, Sandrine Frybourg, Sylvie Gabriel, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
International Journal of Technology Assessment in Health Care
|
May 24, 2022
Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework - Corrigendum
Amanda Whittal, Claudio Jommi, Gérard De Pouvourville, et al.
International Journal of Technology Assessment in Health Care
|
March 11, 2022
Facilitating [corrected] More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework
Amanda Whittal, Claudio Jommi, Gérard De Pouvourville, et al.
BMC Health Services Research
|
January 23, 2024
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Maria Caterina Cavallo, Marianna Cavazza, Francesca Bonifazi, et al.
Bioactive Materials
|
July 17, 2023
Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access
Lorella Giovannelli, Elia Bari, Claudio Jommi, et al.
Health Policy (Amsterdam, Netherlands)
|
May 18, 2019
Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency
Federico Villa, Michaela Tutone, Gianluca Altamura, et al.
Applied Health Economics and Health Policy
|
August 9, 2018
Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates
Jaime Espin, Michael Schlander, Brian Godman, et al.
Health Economics Review
|
November 26, 2025
Horizon scanning and drug expenditure for rare diseases: three-year predictive model in Italy 2025-2027
Andrea Marcellusi, Daniela Cazzato, Giulio Guarnotta, et al.
Frontiers in Medicine
|
June 16, 2023
Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries
Miguel Á Canales Albendea, Pier Luigi Canonico, Guillaume Cartron, et al.
Pharmacoeconomics - Open
|
April 7, 2018
The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational Study
Claudio Jommi, Patrizio Armeni, Margherita Battista, et al.
Journal of Market Access & Health Policy
|
July 26, 2017
Unlocking the potential of established products: toward new incentives rewarding innovation in Europe
Gabrielle Nayroles, Sandrine Frybourg, Sylvie Gabriel, et al.
Page
of 9